Neonate with bilateral breast enlargementA 10-day-old female infant presented to the clinic for a weight check. She was feeding well, but her mother was concerned about her newly swollen breasts.
Impact of aspirin in reducing preterm preeclampsiaA study looks at the efficacy of aspirin in reducing preterm preeclampsia. Plus: The CDC reports on antidepressant use in the United States. Also, a look at whether vaginal estrogen postmenopause increases the risk of heart disease and certain types of cancer.
POAG: Enigmatic group of heterogenous diseases?Various subtypes of primary open-angle glaucoma might exist. Continued research is needed to identify the characteristics of each subtype for better management.
Natural estrogen/progesterone HT capsule shows promiseA first-of-its-kind capsule combining natural 17β-estradiol and progesterone has promise for menopause-related hot flushes, according to results of a Phase 3 multi center trial.
Can low-dose estrogen bring vasomotor symptom relief?A study examines the efficacy of lower-than-conventional doses of estrogen in relieving vasomotor symptoms. Plus: What are the latest ACOG recommendations on water births?
Low Estrogen could mean low Testosterone (VIDEO)Low testosterone is often blamed for a lower sex drive and potentially dangerous fat accumulation in men, however researchers from Massachusetts General Hospital report that a lack of estrogen is also to blame. Video provided by Renal & Urology News.
Study shows estrogen levels are unrelated to cognition in postmenopausal womenA new study examines the cognitive affects of sex hormones on postmenopausal women.
Pesticides may impact endometriosis riskExposure to two organochlorine pesticides may increase risk of endometriosis, according to a new study published in Environmental Health Perspectives.
FDA approves drug for postmenopausal symptomsThe first drug combining estrogens with bazedoxifene has been approved by the U.S. Food and Drug Administration (FDA) for treatment of moderate-to-severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis.
NAMS updates recommendations for vulvovaginal atrophyEstrogen therapy is still the mainstay of therapy for moderate-to-severe symptoms and long-term studies on endometrial safety of local estrogen and ospemifene are lacking. Those are the key conclusions from an updated position statement on management of symptomatic vulvovaginal atrophy (VVA) in postmenopausal women issued by the North American Menopause Society (NAMS).